We are live on ! Find out more
PHXM

PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM

Delisted

PHXM was delisted on the 8th of March, 2024.

Back to rankings

3 hedge funds and large institutions have $8.95M invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% less funds holding

Funds holding: 4 → 3 (-1)

25% less capital invested

Capital invested by funds: $12M → $8.95M (-$3.04M)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$105K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$106K
2
Morgan Stanley
Morgan Stanley
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$4.47M – – –
NMC
2
NEA Management Company
Maryland
$4.4M – – –
Citadel Advisors
3
Citadel Advisors
Florida
$81K +$105K +1,134 New
Millennium Management
4
Millennium Management
New York
– -$106K -1,083 Closed
Morgan Stanley
5
Morgan Stanley
New York
– -$1K -10 Closed

PHXM Hedge Fund Activity: Q1 2021 in Review

3 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) for Q1 2021, worth a combined $8.95M — down 25% from $12M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PHXM and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $105K. The largest seller was Millennium Management, exiting entirely with an estimated $106K sold.

  • 3 institutional investors held PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) as of Q1 2021, down from 4 in Q4 2020.
  • Funds reported $8.95M of PHAXIAM Therapeutics S.A.. American Depositary Shares stock for Q1 2021, down 25% quarter-over-quarter.
  • 1 fund opened new PHAXIAM Therapeutics S.A.. American Depositary Shares positions in Q1 2021 and 2 closed out, a net change of -1 holder.
  • The largest PHAXIAM Therapeutics S.A.. American Depositary Shares buyer in Q1 2021 was Citadel Advisors, an estimated $105K added.
  • The largest PHAXIAM Therapeutics S.A.. American Depositary Shares seller in Q1 2021 was Millennium Management, an estimated $106K sold.

Based on aggregated 13F filings for Q1 2021.